Details for New Drug Application (NDA): 091442
✉ Email this page to a colleague
The generic ingredient in BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is brimonidine tartrate; timolol maleate. There are eleven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.
Summary for 091442
Tradename: | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE |
Applicant: | Apotex |
Ingredient: | brimonidine tartrate; timolol maleate |
Patents: | 0 |
Pharmacology for NDA: 091442
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Antagonists |
Suppliers and Packaging for NDA: 091442
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 091442 | ANDA | Apotex Corp. | 60505-0589 | 60505-0589-1 | 1 BOTTLE, DROPPER in 1 CARTON (60505-0589-1) / 5 mL in 1 BOTTLE, DROPPER |
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 091442 | ANDA | Apotex Corp. | 60505-0589 | 60505-0589-2 | 1 BOTTLE, DROPPER in 1 CARTON (60505-0589-2) / 10 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.2%;EQ 0.5% BASE | ||||
Approval Date: | Apr 20, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription